111

SINPHAR PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Market capitalization
‪6.11 B‬TWD
‪375.17 M‬TWD
‪2.96 B‬TWD
‪152.30 M‬
Beta (1Y)
0.28

About SINPHAR PHARMACEUTICAL CO LTD

CEO
Yu-Liang Pei
Headquarters
I-lan
Founded
1977
ISIN
TW0001734002
FIGI
BBG000F89247
Sinphar Pharmaceutical Co. Ltd. engages in the production, processing, and trading of medicines, Chinese medicines, medical cosmetic products, and nutrients. It operates through the following segments: Pharmaceutical, Healthy Food, and Others. The company was founded on July 2, 1977 and is headquartered in I-lan, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1734 is 35.70 TWD — it has decreased by 1.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SINPHAR PHARMACEUTICAL CO LTD stocks are traded under the ticker 1734.
SINPHAR PHARMACEUTICAL CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
1734 stock is 3.12% volatile and has beta coefficient of 0.28. Check out the list of the most volatile stocks — is SINPHAR PHARMACEUTICAL CO LTD there?
Yes, you can track SINPHAR PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
1734 stock has fallen by 3.51% compared to the previous week, the month change is a 0.83% fall, over the last year SINPHAR PHARMACEUTICAL CO LTD has showed a 9.17% increase.
1734 net income for the last quarter is ‪109.85 M‬ TWD, while the quarter before that showed ‪76.17 M‬ TWD of net income which accounts for 44.23% change. Track more SINPHAR PHARMACEUTICAL CO LTD financial stats to get the full picture.
Today SINPHAR PHARMACEUTICAL CO LTD has the market capitalization of ‪6.11 B‬, it has increased by 2.86% over the last week.
Yes, 1734 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 2.75%. Tracking SINPHAR PHARMACEUTICAL CO LTD dividends might help you take more informed decisions.
SINPHAR PHARMACEUTICAL CO LTD dividend yield was 2.95% in 2023, and payout ratio reached 44.70%. The year before the numbers were 3.02% and 74.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1734 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINPHAR PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
1734 reached its all-time high on Jul 13, 2020 with the price of 68.50 TWD, and its all-time low was 13.05 TWD and was reached on Jul 18, 2006.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINPHAR PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINPHAR PHARMACEUTICAL CO LTD stock shows the buy signal. See more of SINPHAR PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINPHAR PHARMACEUTICAL CO LTD EBITDA is ‪529.58 M‬ TWD, and current EBITDA margin is 17.87%. See more stats in SINPHAR PHARMACEUTICAL CO LTD financial statements.